[HTML][HTML] Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation

H Tan, Y Gong, Y Liu, J Long, Q Luo, OD Faleti… - Biomedicine & …, 2023 - Elsevier
Epstein-Barr virus (EBV) is a widespread human herpes virus associated with lymphomas
and epithelial cell cancers. It establishes two separate infection phases, latent and lytic, in …

Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress

DK DePalo, JS Zager - Cancers, 2023 - mdpi.com
Simple Summary The prognosis for patients with locoregionally advanced and metastatic
melanoma remains poor despite advances in systemic therapy. By delivering therapeutics …

The expression and function of HSV ICP47 and its promoter in mice

T Velusamy, N Singh, S Croft, S Smith… - Journal of …, 2023 - Am Soc Microbiol
Herpes simplex virus (HSV) protein immediate early-infected cell protein (ICP) 47 inhibits
the transporter associated with antigen presentation, thereby concealing infected cells from …

Varicella Zoster Virus Impairs Expression of the Nonclassical Major Histocompatibility Complex Class I–Related Gene Protein (MR1)

SK Purohit, C Samer, HEG McWilliam… - The Journal of …, 2023 - academic.oup.com
The antigen presentation molecule MR1 (major histocompatibility complex, class I–related)
presents ligands derived from the riboflavin (vitamin B) synthesis pathway, which is not …

Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models

K Inoue, H Ito, M Iwai, M Tanaka, Y Mori… - Molecular Therapy …, 2023 - cell.com
A complete resection of tongue cancer is often difficult. We investigate the usefulness of
administering G47Δ (teserpaturev), a triple-mutated oncolytic herpes simplex virus type 1 …

The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors

MS Kamel, RA Munds, MS Verma - International Journal of Molecular …, 2023 - mdpi.com
Herpesviruses are large DNA viruses that have long been used as powerful gene therapy
tools. In recent years, the ability of herpesviruses to stimulate both innate and adaptive …

Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12

H Fukuhara, YT Sato, J Hou, M Iwai… - Communications Medicine, 2023 - nature.com
Background G47∆ is a triple-mutated oncolytic herpes simplex virus type 1 (HSV-1) recently
approved as a new drug for malignant glioma in Japan. As the next-generation, we develop …

Genetic engineering of animal DNA viruses in order to study and modify pathogenesis

DA Leib - Genetically Engineered Viruses, 2023 - taylorfrancis.com
Amongst the DNA viruses, the herpesvirus family has been perhaps the most extensively
studied in terms of genetics and pathogenesis, and will therefore be the primary focus for …